3 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Yehui Tan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes VEN (Venetoclax) - Myelodysplastic Neoplasms, Transplantation | Phase 2 | Recruiting | Yehui Tan | 46 | 2025-07-01 | 2025-08-08 |
| Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia Intermediate-dose Cytarabine in Combination with Venetoclax - Acute Myeloid Leukemia (AML), Elderly | Phase 3 | Recruiting | Yehui Tan | 68 | 2025-06-01 | 2025-08-08 |
| Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease Venetoclax - Acute Myeloid Leukemia (AML) | Phase 2 | Recruiting | Yehui Tan | 70 | 2025-06-01 | 2025-08-08 |
venetoclax (3) · Azacitidine (1)
China (3)